Howard Her 25th International Pathogenic Neisseria Conference 2026

Abstracts this author is presenting:

• First clinical trial results in the Phase 2/3 study of the EuBiologics pentavalent meningococcal ACWYX conjugate vaccine compared to Nimenrix® in healthy children aged 12-23-month-old in The Gambia — Session 9 - The African Meningitis Belt